Concepedia

Sheryl L. Windsor

SL

Statistics

Publications

24

Citations

3.5K

H-Index

19

Active since

1990

Affiliations

Saint Luke's Hospital(Current)

University of Missouri–Kansas City

The George Institute for Global Health

Wake Forest University

University of Kansas Medical Center

Sheryl L. Windsor is an author at Saint Luke's Hospital specializing in medicine, cardiovascular disease, and physiology.

ORCID

Top concepts

Publications per year

1990–2024

24

Publications

24

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug et al. · Nature Medicine · 2021 · 572 citations · Full text

, , +14

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction

Michael E. Nassif, Sheryl L. Windsor, Fengming Tang et al. · Circulation · 2019 · 415 citations

Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients

William S. Harris, Scott A. Sands, Sheryl L. Windsor et al. · Circulation · 2004 · 319 citations

Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

W.S. Harris, Henry N. Ginsberg, Narin Arunakul et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 1997 · 305 citations

Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure

Michael E. Nassif, Mohammed Qintar, Sheryl L. Windsor et al. · Circulation · 2021 · 261 citations · Full text

1–5 of 24